International Biotechnology Trust’s Enanta Pharmaceuticals ENTA Stock Holding History

International Biotechnology Trust’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40,000	Closed	-$2.26M	–	77
2021 Q3	$2.26M	Buy	40,000 +5,953	+17%	+$294K	0.55%	38
2021 Q2	$1.5M	Buy	+34,047	New	+$1.67M	0.4%	44
2020 Q3	–	Sell	-46,500	Closed	-$2.28M	–	54
2020 Q2	$2.28M	Hold	46,500	–	–	0.76%	25
2020 Q1	$2.38M	Buy	+46,500	New	+$2.48M	1.09%	22
2019 Q2	–	Sell	-61,000	Closed	-$5.83M	–	65
2019 Q1	$5.83M	Buy	61,000 +18,000	+42%	+$1.61M	2.15%	16
2018 Q4	$2.39M	Buy	+43,000	New	+$3.3M	1.48%	22

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

International Biotechnology Trust's ENTA Position: Q4 2021 in Review

International Biotechnology Trust sold out of Enanta Pharmaceuticals (ENTA) in Q4 2021, closing a stake of 40,000 shares — an estimated $2.26M sold.

International Biotechnology Trust first reported a position in ENTA in Q4 2018 and held it in 6 quarters. The position peaked at $5.83M in Q1 2019. 179 funds tracked by Wall St. Rank hold ENTA as of Q4 2021.

International Biotechnology Trust reported no remaining Enanta Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
International Biotechnology Trust sold 40,000 Enanta Pharmaceuticals shares in Q4 2021, an estimated $2.26M.
International Biotechnology Trust first reported a position in Enanta Pharmaceuticals in Q4 2018 and held it in 6 quarters.
International Biotechnology Trust's Enanta Pharmaceuticals position peaked at $5.83M in Q1 2019.
179 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2021.

Based on International Biotechnology Trust's 13F filing for Q4 2021, filed 15 Feb 2022.